Teva Pharma (TEVA) PT Raised to $41 at Piper Sandler; 'Much To Be Bullish About'
Tweet Send to a Friend
Piper Sandler analyst David Amsellem raised the price target on Teva Pharma (NYSE: TEVA) to $41.00 (from $40.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
